Messages From the Director
Messages from the Director
February 2012
November 2011
September 2011
August 2011
June 2011
May 2011
February 2011
January 2011
December 2010
October 2010
December 2009
February 2009
December 2008
January 2008
February 2007
October 2005
September 2005
August 2005
American Recovery and Reinvestment Act (ARRA)
February 2009
On February 17, President Obama signed the American Recovery and Reinvestment Act of 2009 (ARRA). Among the goals of the ARRA are to preserve and create jobs, promote economic recovery, and provide investments to increase economic efficiency by spurring technological advances in science and health.
NIH is grateful for the opportunity afforded by the ARRA to provide economic stimulus to the nation while furthering our mission to uncover new knowledge that will lead to better health for everyone. NIH will receive $10 billion through the ARRA for use over the next two years (2009 and 2010). Of this, $1 billion will be invested in extramural construction (administered through the National Center for Research Resources), $0.8 billion will be provided to the Office of the NIH Director for extending and developing appropriate programs, and $7.4 billion will be provided to the NIH institutes and centers (proportional to their appropriations).
Staff throughout NIH, including those at NIDA, are working diligently to determine how to invest these resources. A major consideration is that these funds must be distributed over the next two years to meet the goals of the ARRA.
We are aware of how interested you are in these programs and will be providing more details as they become available.
Sincerely,
Nora D. Volkow, M.D.
Director
For more information on the American Recovery and Reinvestment Act (ARRA):
This page was last updated February 2009.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
External link, please review our disclaimer.
External link, please review our disclaimer.
External link, please review our disclaimer.




